Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - AGILE THERAPEUTICS INC | a2220037zs-1a.htm |
| EX-4.4 - EX-4.4 - AGILE THERAPEUTICS INC | a2220037zex-4_4.htm |
| EX-10.9 - EX-10.9 - AGILE THERAPEUTICS INC | a2220037zex-10_9.htm |
| EX-23.3 - EX-23.3 - AGILE THERAPEUTICS INC | a2220037zex-23_3.htm |
| EX-10.1 - EX-10.1 - AGILE THERAPEUTICS INC | a2220037zex-10_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 17, 2014, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-194621) and related Prospectus of Agile Therapeutics, Inc. dated May 5, 2014 for the registration of 000,000 shares of its common stock.
| /s/ Ernst & Young LLP |
Metropark, New Jersey
May 5, 2014
Consent of Independent Registered Public Accounting Firm